Valeant Asks Allergan To Open Talks, Tone Down Buyout Fight
On the heels of a better-than-expected earnings forecast, Valeant Pharmaceuticals International Inc. made clear on Wednesday it was still hoping to meet Allergan Inc. at the bargaining table, five months after...To view the full article, register now.
Already a subscriber? Click here to view full article